Thomas E. Prisinzano

7.1k total citations
178 papers, 5.4k citations indexed

About

Thomas E. Prisinzano is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Thomas E. Prisinzano has authored 178 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Cellular and Molecular Neuroscience, 109 papers in Molecular Biology and 37 papers in Physiology. Recurrent topics in Thomas E. Prisinzano's work include Neuropeptides and Animal Physiology (88 papers), Receptor Mechanisms and Signaling (79 papers) and Neurotransmitter Receptor Influence on Behavior (51 papers). Thomas E. Prisinzano is often cited by papers focused on Neuropeptides and Animal Physiology (88 papers), Receptor Mechanisms and Signaling (79 papers) and Neurotransmitter Receptor Influence on Behavior (51 papers). Thomas E. Prisinzano collaborates with scholars based in United States, New Zealand and Italy. Thomas E. Prisinzano's co-authors include Richard B. Rothman, Bronwyn M. Kivell, Kevin Tidgewell, Wayne W. Harding, Christina M. Dersch, Eduardo R. Butelman, Laura Bohn, Matthew Schmidt, Mary Jeanne Kreek and Chad E. Groer and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Thomas E. Prisinzano

174 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Prisinzano United States	45	3.2k	2.9k	918	828	597	178	5.4k
Linda P. Dwoskin United States	47	3.9k 1.2×	4.5k 1.5×	981 1.1×	951 1.1×	226 0.4×	259	7.6k
F. Ivy Carroll United States	50	4.5k 1.4×	4.4k 1.5×	761 0.8×	1.3k 1.5×	296 0.5×	305	8.0k
Silvio Caccia Italy	44	2.4k 0.8×	1.5k 0.5×	584 0.6×	485 0.6×	440 0.7×	194	5.8k
Christina M. Dersch United States	31	2.4k 0.7×	1.8k 0.6×	347 0.4×	596 0.7×	211 0.4×	107	3.5k
Aaron Janowsky United States	43	3.5k 1.1×	2.6k 0.9×	477 0.5×	430 0.5×	125 0.2×	129	5.5k
Vincent Setola United States	33	1.8k 0.5×	2.8k 1.0×	290 0.3×	634 0.8×	300 0.5×	81	5.1k
F. Ivy Carroll United States	36	3.0k 0.9×	3.4k 1.2×	644 0.7×	772 0.9×	174 0.3×	169	5.2k
Choon‐Gon Jang South Korea	41	1.8k 0.6×	2.1k 0.7×	801 0.9×	160 0.2×	1.3k 2.1×	283	6.6k
Hans Rommelspacher Germany	43	2.5k 0.8×	2.3k 0.8×	553 0.6×	635 0.8×	165 0.3×	178	5.4k
C. J. E. Niemegeers Belgium	44	4.0k 1.2×	2.7k 0.9×	885 1.0×	610 0.7×	414 0.7×	148	7.5k

Countries citing papers authored by Thomas E. Prisinzano

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Prisinzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Prisinzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Prisinzano more than expected).

Fields of papers citing papers by Thomas E. Prisinzano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Prisinzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Prisinzano. The network helps show where Thomas E. Prisinzano may publish in the future.

Co-authorship network of co-authors of Thomas E. Prisinzano

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Prisinzano. A scholar is included among the top collaborators of Thomas E. Prisinzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Prisinzano. Thomas E. Prisinzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biggerstaff, Andrew, et al.. (2025). Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol. Neuropsychopharmacology. 50(12). 1777–1786.

Luo, Dan, Michael D. Sunshine, Jill Turner, et al.. (2024). Targeting α1- and α2-adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression. Environmental Toxicology and Pharmacology. 110. 104527–104527. 2 indexed citations

Prisinzano, Thomas E., et al.. (2024). Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice. Glia. 72(10). 1801–1820. 1 indexed citations

Sulima, Agnieszka, Dan Luo, Sophia Kaska, et al.. (2024). Functional Activity of Enantiomeric Oximes and Diastereomeric Amines and Cyano Substituents at C9 in 3-Hydroxy-N-phenethyl-5-phenylmorphans. Molecules. 29(9). 1926–1926. 1 indexed citations

Sulima, Agnieszka, et al.. (2023). A MOR Antagonist with High Potency and Antagonist Efficacy among Diastereomeric C9-Alkyl-Substituted N-Phenethyl-5-(3-hydroxy)phenylmorphans. Molecules. 28(14). 5411–5411. 3 indexed citations

Kivell, Bronwyn M., et al.. (2023). KAPPA OPIOID RECEPTOR AGONISTS MODULATE THE ANTI-INFLAMMATORY ACTIONS OF MICROGLIA AND PROMOTE OLIGODENDROCYTE MATURATION AND MYELIN REPAIR IN PRECLINICAL MODELS OF MULTIPLE SCLEROSIS.. IBRO Neuroscience Reports. 15. S592–S592. 1 indexed citations

Ewald, Amy, et al.. (2023). The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules. 28(12). 4848–4848. 7 indexed citations

Sulima, Agnieszka, Eugene S. Gutman, Dan Luo, et al.. (2023). Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans. Molecules. 28(12). 4795–4795. 11 indexed citations

Prisinzano, Thomas E., et al.. (2021). Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. Clinical & Translational Immunology. 10(1). e1234–e1234. 19 indexed citations

10.

Butelman, Eduardo R., et al.. (2021). Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice. Journal of Psychopharmacology. 35(5). 579–590. 5 indexed citations

11.

Prisinzano, Thomas E., et al.. (2021). Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice. Frontiers in Pharmacology. 12. 1 indexed citations

12.

Luo, Dan, Sophia Kaska, R.J. Sarma, et al.. (2021). Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent. Journal of Biomedical Science. 28(1). 62–62. 13 indexed citations

13.

Gutman, Eugene S., Fuying Li, Agnieszka Sulima, et al.. (2020). G-Protein biased opioid agonists: 3-hydroxy-N-phenethyl-5-phenylmorphans with three-carbon chain substituents at C9. RSC Medicinal Chemistry. 11(8). 896–904. 12 indexed citations

14.

Kivell, Bronwyn M., et al.. (2018). Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules. 23(10). 2602–2602. 37 indexed citations

15.

Mereu, Maddalena, Lauren E. Chun, Thomas E. Prisinzano, et al.. (2016). The unique psychostimulant profile of (±)‐modafinil: investigation of behavioral and neurochemical effects in mice. European Journal of Neuroscience. 45(1). 167–174. 32 indexed citations

16.

Marchant, Nathan J., Erin J. Campbell, Leslie R. Whitaker, et al.. (2016). Role of Ventral Subiculum in Context-Induced Relapse to Alcohol Seeking after Punishment-Imposed Abstinence. Journal of Neuroscience. 36(11). 3281–3294. 90 indexed citations

17.

Marchant, Nathan J., Leslie R. Whitaker, Jennifer M. Bossert, et al.. (2015). Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats. Neuropsychopharmacology. 41(2). 402–409. 51 indexed citations

18.

Lamb, Kenneth, Kevin Tidgewell, Denise S. Simpson, Laura Bohn, & Thomas E. Prisinzano. (2011). Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology. Drug and Alcohol Dependence. 121(3). 181–188. 53 indexed citations

19.

Roychowdhury, Sanjoy, Farah Khan, Thomas E. Prisinzano, et al.. (2006). Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450. Journal of Pharmacology and Experimental Therapeutics. 319(1). 488–496. 33 indexed citations

20.

Schmidt, Mark S., Thomas E. Prisinzano, Kevin Tidgewell, et al.. (2005). Determination of Salvinorin A in body fluids by high performance liquid chromatography–atmospheric pressure chemical ionization. Journal of Chromatography B. 818(2). 221–225. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact